These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18303262)

  • 1. Pharmacokinetics and pharmacodynamic assessment of imipenem in the intraperitoneal fluid of abdominal surgery patients.
    Ikawa K; Morikawa N; Sakamoto K; Ikeda K; Ohge H; Takesue Y; Sueda T
    Chemotherapy; 2008; 54(2):131-9. PubMed ID: 18303262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic profiling of cefepime in plasma and peritoneal fluid of abdominal surgery patients.
    Ikawa K; Morikawa N; Hayato S; Ikeda K; Ohge H; Sueda T
    Int J Antimicrob Agents; 2007 Sep; 30(3):270-3. PubMed ID: 17587550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic assessment of doripenem in peritoneal fluid against Gram-negative organisms: use of population pharmacokinetic modeling and Monte Carlo simulation.
    Ikawa K; Morikawa N; Ikeda K; Ohge H; Sueda T
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):292-7. PubMed ID: 18703305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal penetration and pharmacodynamic exposure of intravenous cefozopran in abdominal surgery patients.
    Ikawa K; Morikawa N; Matsuda S; Ikeda K; Ohge H; Takesue Y; Sueda T
    Int J Antimicrob Agents; 2007 Oct; 30(4):352-5. PubMed ID: 17644344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Monte Carlo simulation to assess the pharmacodynamics of beta-lactams against Pseudomonas aeruginosa infections in children: a report from the OPTAMA program.
    Ellis JM; Kuti JL; Nicolau DP
    Clin Ther; 2005 Nov; 27(11):1820-30. PubMed ID: 16368453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration and exposure of cefotiam into the peritoneal fluid of abdominal surgery patients after intravenous administration.
    Ikawa K; Morikawa N; Fukuhara K; Hayato S; Ikeda K; Soga Y; Ohge H; Sueda T
    J Chemother; 2008 Jun; 20(3):319-23. PubMed ID: 18606586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal pharmacokinetics of cefepime in laparotomy patients with inflammatory bowel disease, and dosage considerations for surgical intra-abdominal infections based on pharmacodynamic assessment.
    Higuchi K; Ikawa K; Ikeda K; Ohge H; Sueda T; Houchi H; Morikawa N
    J Infect Chemother; 2008 Apr; 14(2):110-6. PubMed ID: 18622673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of breakpoints of carbapenems for intraabdominal infections based on pharmacokinetics and pharmacodynamics in peritoneal fluid.
    Ikawa K; Morikawa N; Ikeda K; Ohge H; Sueda T
    J Infect Chemother; 2008 Aug; 14(4):330-2. PubMed ID: 18709540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal pharmacokinetics and pharmacodynamic target attainment of meropenem in patients undergoing abdominal surgery.
    Soga Y; Ohge H; Ikawa K; Morikawa N; Ikeda K; Sueda T
    J Chemother; 2010 Apr; 22(2):98-102. PubMed ID: 20435568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis.
    Nomura K; Morikawa N; Ikawa K; Ikeda K; Fujimoto Y; Shimizu D; Taniguchi K; Shimura K; Kanbayashi Y; Komori T; Matsumoto Y; Fujita N; Shimazaki C; Taniwaki M
    J Antimicrob Chemother; 2008 Apr; 61(4):892-900. PubMed ID: 18276604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulated comparison of the pharmacodynamics of ciprofloxacin and levofloxacin against Pseudomonas aeruginosa using pharmacokinetic data from healthy volunteers and 2002 minimum inhibitory concentration data.
    Burgess DS; Hall RG
    Clin Ther; 2007 Jul; 29(7):1421-7. PubMed ID: 17825693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimisation of imipenem regimens in patients with impaired renal function by pharmacokinetic-pharmacodynamic target attainment analysis of plasma and urinary concentration data.
    Yoshizawa K; Ikawa K; Ikeda K; Kumon H; Ohge H; Morikawa N
    Int J Antimicrob Agents; 2012 Nov; 40(5):427-33. PubMed ID: 22877766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic evaluation of biapenem in peritoneal fluid using population pharmacokinetic modelling and Monte Carlo simulation.
    Ikawa K; Morikawa N; Ikeda K; Ohge H; Sueda T
    Int J Antimicrob Agents; 2008 Oct; 32(4):339-43. PubMed ID: 18602798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistance.
    Crandon JL; Kuti JL; Jones RN; Nicolau DP
    Ann Pharmacother; 2009 Feb; 43(2):220-7. PubMed ID: 19193582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ertapenem peritoneal fluid concentrations in adult surgical patients.
    Arrigucci S; Garcea A; Fallani S; Cassetta MI; Canonico G; Tonelli F; Mazzei T; Novelli A
    Int J Antimicrob Agents; 2009 Apr; 33(4):371-3. PubMed ID: 19097758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J; Villiger P; Caviezel A; Matulionyte R; Uckay I; Morel P; Lew D
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic-pharmacodynamic target attainment analysis of imipenem plasma and urine data in neonates and children.
    Yoshizawa K; Ikawa K; Ikeda K; Ohge H; Morikawa N
    Pediatr Infect Dis J; 2013 Nov; 32(11):1208-16. PubMed ID: 23676856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state pharmacokinetics and pharmacodynamics of meropenem in hospitalized patients.
    Cheatham SC; Kays MB; Smith DW; Wack MF; Sowinski KM
    Pharmacotherapy; 2008 Jun; 28(6):691-8. PubMed ID: 18503396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of heated intraperitoneal oxaliplatin.
    Ferron G; Dattez S; Gladieff L; Delord JP; Pierre S; Lafont T; Lochon I; Chatelut E
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):679-83. PubMed ID: 18084764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of imipenem-cilastatin following intravenous administration in healthy adult horses.
    Orsini JA; Moate PJ; Boston RC; Norman T; Engiles J; Benson CE; Poppenga R
    J Vet Pharmacol Ther; 2005 Aug; 28(4):355-61. PubMed ID: 16050815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.